| Followers | 47 |
| Posts | 23805 |
| Boards Moderated | 0 |
| Alias Born | 09/16/2012 |
Friday, August 16, 2024 6:28:05 PM
"I'm almost certain they didn't get exercised" means there's a possibility.
Not when they're gifted. Take the money and run is the better strategy unless management is adamant they hold.
>>The value of options is in the time value and these have 5 years on them.
You don't know that. How many times have we seen OTC stocks crash and burn as execs make out like bandits with options? We all know if management was seen selling on quick pops the share price would be destroyed even further so "Gifting" could be a way around it.
>>The people who gifted them believe in the future value of the company. Sorry to break it to you but it's not a scam and they hardly think it's a good idea to cash out anything at the 52-week low.
Looks to me like it could be an exercise at 35 cents and they would be reflected in shares outstanding. Except they're pouring so many shares into the outstanding count that it makes it difficult to detect.
>>As long as the options are not exercised and stock sold, zero impact on trading. Most people don't even know what the strike price is. So how are they going to influence today's trading, please explain your theory.
Legacy shareholders are down 99.X% of their hard earned money as management gifts options to their family members who could be getting wealthy on quick well timed sells. But I don't know that for sure. I was hoping for more input from others here.
>>Why are you so obsessed with this? Don't you know how much wealth has been generated for so many via stock options in tech and biotech, down to ordinary engineers?
It's appalling. Thou doth protest too much. I wish others would chime in but it seems like you're the only one interested.
>>Personally I think the true up was a bit overdone but the votes show that almost nobody agrees with me. If it upsets your personal sense of value you need to get over it - you are seeing nothing if that skews your view completely. jmo.
Not when they're gifted. Take the money and run is the better strategy unless management is adamant they hold.
>>The value of options is in the time value and these have 5 years on them.
You don't know that. How many times have we seen OTC stocks crash and burn as execs make out like bandits with options? We all know if management was seen selling on quick pops the share price would be destroyed even further so "Gifting" could be a way around it.
>>The people who gifted them believe in the future value of the company. Sorry to break it to you but it's not a scam and they hardly think it's a good idea to cash out anything at the 52-week low.
Looks to me like it could be an exercise at 35 cents and they would be reflected in shares outstanding. Except they're pouring so many shares into the outstanding count that it makes it difficult to detect.
>>As long as the options are not exercised and stock sold, zero impact on trading. Most people don't even know what the strike price is. So how are they going to influence today's trading, please explain your theory.
Legacy shareholders are down 99.X% of their hard earned money as management gifts options to their family members who could be getting wealthy on quick well timed sells. But I don't know that for sure. I was hoping for more input from others here.
>>Why are you so obsessed with this? Don't you know how much wealth has been generated for so many via stock options in tech and biotech, down to ordinary engineers?
It's appalling. Thou doth protest too much. I wish others would chime in but it seems like you're the only one interested.
>>Personally I think the true up was a bit overdone but the votes show that almost nobody agrees with me. If it upsets your personal sense of value you need to get over it - you are seeing nothing if that skews your view completely. jmo.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
